Bevacizumab/doxorubicin liposomalReversible posterior leukoencephalopathy syndrome: case report

被引:0
作者
机构
关键词
Breast Cancer; Doxorubicin; Meningitis; Bevacizumab; Mannitol;
D O I
10.2165/00128415-200811910-00015
中图分类号
学科分类号
摘要
引用
收藏
页码:6 / 6
相关论文
共 50 条
[31]   Isolated brainstem involvement in posterior reversible leukoencephalopathy induced by bevacizumab [J].
G. El Maalouf ;
E. Mitry ;
A. Lacout ;
A. Lièvre ;
P. Rougier .
Journal of Neurology, 2008, 255 :295-296
[33]   Reversible posterior leukoencephalopathy syndrome in cancer [J].
Christopher Vaughn ;
Louann Zhang ;
David Schiff .
Current Oncology Reports, 2008, 10 :86-91
[34]   Bevacizumab in combination with oxaliplatin and doxorubicin or liposomal doxorubicin for hepatocellular cancer: A case series [J].
Ku, Geoffrey Y. ;
Lopes, Gilberto De Lima, Jr. ;
Chang, Alex Y. .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (02) :174-179
[35]   Fatal posterior revesible leukoencephalopathy syndrome associated coma induced by bevacizumab in metastatic colorectal cancer and review of literature [J].
Eryilmaz, Melek Karakurt ;
Mutlu, Hasan ;
Salim, Derya Kivrak ;
Musri, Fatma Yalcin ;
Coskun, Hasan Senol .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2016, 22 (06) :806-810
[36]   Reversible Posterior Leukoencephalopathy Syndrome Induced by Vinorelbine [J].
Chen, Yen-Hao ;
Huang, Cheng-Hua .
CLINICAL BREAST CANCER, 2012, 12 (03) :222-225